RFK Jr's appointment in health could accelerate psychedelic drug development, analysts say
Portfolio Pulse from
RFK Jr's potential role in health policy under President-elect Trump could boost psychedelic drug development, as he supports this drug class. Analysts at Jefferies highlight his positive inclination towards psychedelics, which have reportedly aided his family and friends.
November 12, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RFK Jr's potential influence in health policy could benefit ATAI Life Sciences, a company involved in psychedelic drug development, due to his support for the sector.
RFK Jr's support for psychedelic drugs and his potential role in shaping health policy could lead to favorable regulatory conditions for companies like ATAI Life Sciences, which focuses on psychedelic drug development.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80